Exposure to a Tobacco-Specific Lung Carcinogen in Adolescent versus Adult Smokers

Background: Previous studies with adult smokers have shown an association between number of cigarettes smoked per day (CPD) and levels of biomarkers of exposure to the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). This study compared carcinogen and nicotine exposure in adolescent and adult smokers across categories of CPD. Method: Baseline smoking history and biomarker data were merged from six studies to make two samples: one of adolescent smokers and one of adult smokers. Metabolites of NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), and its glucuronides (NNAL-Gluc) and total cotinine were quantified in urine. Results: CPD was stratified into categories of 5 to 10, 11 to 15, and 16 to 20 CPD. Adolescents tended to have lower mean levels of NNAL plus NNAL-Glucs (total NNAL) compared with adults, although differences were not significant overall. Adolescent mean levels of NNAL/CPD were significantly lower than adult levels only in the 11 to 15 CPD category (P = 0.045). However, a significant positive relationship was observed for total NNAL/CPD by age. No significant differences between adolescents and adults were found in mean levels of total cotinine or cotinine/CPD. A subsample of urines from adolescents and adults were analyzed for NNAL-Glucs and NNAL. Adolescents and adults did not significantly differ in the ratio of NNAL-Glucs to NNAL. Conclusions: Adolescent uptake of NNK and nicotine tends to be lower although not statistically different from adults. The lack of significant differences may be due to the wide variation in exposure in adolescents. Some adolescent smokers are exposed to lung carcinogens at levels similar to those of adults. (Cancer Epidemiol Biomarkers Prev 2008;17(12):3337–43)

[1]  D. Hatsukami,et al.  Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen. , 2004, Journal of the National Cancer Institute.

[2]  S. Hecht,et al.  Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[3]  K. Emmons,et al.  Respiratory response to cigarette smoking among adolescent smokers: a pilot study. , 1996, Preventive medicine.

[4]  T. Grotmol,et al.  Adolescent smoking and trends in lung cancer incidence among young adults in Norway 1954–1998 , 2004, Cancer Causes & Control.

[5]  D. Dockery,et al.  Effects of cigarette smoking on lung function in adolescent boys and girls. , 1996, The New England journal of medicine.

[6]  D. Hatsukami,et al.  Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. , 1999, Cancer research.

[7]  D. Kandel,et al.  Salivary cotinine concentration versus self-reported cigarette smoking: Three patterns of inconsistency in adolescence. , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[8]  D. Hatsukami,et al.  Similar Uptake of Lung Carcinogens by Smokers of Regular, Light, and Ultralight Cigarettes , 2005, Cancer Epidemiology Biomarkers & Prevention.

[9]  Emily B Zylla,et al.  Cigarette reduction: an intervention for adolescent smokers. , 2008, Drug and alcohol dependence.

[10]  S. Hecht.  Carcinogen biomarkers for lung or oral cancer chemoprevention trials. , 2001, IARC scientific publications.

[11]  S. Shiffman,et al.  Cotinine levels in relation to smoking behavior and addiction in young adolescent smokers. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[12]  T. Perneger,et al.  Saliva cotinine levels in smokers and nonsmokers. , 2000, American journal of epidemiology.

[13]  E. Stice,et al.  Cigarette smoking prospectively predicts retarded physical growth among female adolescents. , 2005, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[14]  R. West,et al.  Nicotine intake in young smokers: longitudinal study of saliva cotinine concentrations. , 1989, American journal of public health.

[15]  Samuel P. Caudill,et al.  Urinary Creatinine Concentrations in the U.S. Population: Implications for Urinary Biologic Monitoring Measurements , 2004, Environmental health perspectives.

[16]  S. Hecht,et al.  Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. , 2002, Carcinogenesis.

[17]  R. Colligan,et al.  Nicotine patch therapy in adolescent smokers. , 1996, Pediatrics.

[18]  Stephen S. Hecht,et al.  Relationships between Cigarette Consumption and Biomarkers of Tobacco Toxin Exposure , 2005, Cancer Epidemiology Biomarkers & Prevention.

[19]  S. Hecht,et al.  Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse. , 1999, Carcinogenesis.

[20]  Office on Smoking.  The Health Consequences of Smoking: A Report of the Surgeon General , 2004 .

[21]  T. Eissenberg,et al.  Acute subjective and physiological responses to smoking in adolescents. , 2001, Addiction.

[22]  A. Malarcher,et al.  Cigarette Smoking Among Adults in the United States , 2008 .

[23]  Virginia Health-System.  Cigarette use among high school students--United States, 1991-2005. , 2006, MMWR. Morbidity and mortality weekly report.

[24]  N. Rigotti,et al.  Initial symptoms of nicotine dependence in adolescents , 2000, Tobacco control.

[25]  W. Riley,et al.  Similar Exposure to a Tobacco-Specific Carcinogen in Smokeless Tobacco Users and Cigarette Smokers , 2007, Cancer Epidemiology Biomarkers & Prevention.

[26]  C. Husten,et al.  Cigarette smoking among adults--United States, 2006. , 2007, MMWR. Morbidity and mortality weekly report.